Q2 2026 saw 8.7% revenue growth and 2.8% higher net income, but payer mix shifts and lower surgical volumes pressured margins. Updated 2026 guidance reflects higher negative impact from uninsured volumes, partially offset by Medicaid program benefits.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.